uploads///SMG Analysts NTM Recommendations and Targets

Analysts’ Targets for Scott Miracle-Gro in April


Dec. 4 2020, Updated 10:53 a.m. ET

Scotts Miracle-Gro

Scotts Miracle-Gro (SMG), unlike Canopy Growth (WEED), Cronos Group (CRON), and Aurora Cannabis (ACB) (ACBFF), isn’t a licensed cannabis producer (HMMJ). However, it supplies products that support the cultivation of cannabis. The company primarily serves the North American market with lawn and garden products such as fertilizers, pesticides, and seeds.

Article continues below advertisement

Analyst ratings

The mean consensus rating for Scotts Miracle-Gro as of April 12, 2018, is 2.3, which is the same as March. The consensus mean recommendation for the stock is a “buy” for the next 12-month period.

In the above chart, you can see that analysts’ recommendations haven’t changed month-over-month. Two analysts are maintaining a “strong buy” recommendation, two are maintaining a “buy” recommendation, and five are maintaining a “hold.”

Price target

While the current ratings on SMG stock are unchanged, its current mean price target has fallen from $102 in March to $100.80 in April. Its median price target also fell from $100 to $97.50. The stock closed at $82.50 on April 12, 2018, giving it a potential upside of 22% over its mean price target and 18% over its median price target.

You may also be interested in reading Key Takeaways from Hydropothecary’s Fiscal 2Q18 Earnings.


More From Market Realist

  • CONNECT with Market Realist
  • Link to Facebook
  • Link to Twitter
  • Link to Instagram
  • Link to Email Subscribe
Market Realist Logo
Do Not Sell My Personal Information

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.